glp 1 agonist parkinson The glucagon-like peptide (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action Repurposing glucagon-like peptide-1 receptor agonists
Pay in 4 interest-free payments of $7.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2



























